Introduction:

Obesity affects millions of persons and there are many treatments for weight loss. The surgical treatments have shown superiority over others. Nevertheless, the number of patients who are candidates is very reduced.

Objectives:

Evaluate the weight loss, body mass index (BMI) and the excess body weight, such as the percentage of excess body weight loss in the patients with adjustable intragastric balloon.

Materials and methods:

We evaluated the patients with adjustable intragastric balloon for weight loss in an endoscopic Mexican center, from March 1, 2017 to March 1, 2018. Weight reduction was evaluated at months 9 and 12. Statistical analysis was applied with Student's t to validate the difference of initial and final means for weight, BMI and excess body weight. In addition, percentage of excess body weight loss were compared with international recommendations. A total of 11 patients met the inclusion criteria and were classified into two registration groups at 9 and 12 months.

Results:

Weight, BMI and excess body weight reduction were statistically significant at 12 months (p < 0.05). The percentage of excess body weight loss reached at 9 months was 34.50% and at 12 months 40.52%.

Conclusions:

The use of adjustable intragastric balloon as a treatment for weight loss in the Mexican population is similar to those reported in the literature, however, it is only a part of the multidisciplinary management for the treatment of obesity.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )